Abgenix Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 440

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.85B

Abgenix General Information

Description

Developer of human therapeutic antibodies. This company develops antibody therapeutic products for the prevention and treatment of a variety of disease conditions, including transplant-related diseases, inflammatory and autoimmune disorders and cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6701 Kaiser Drive
  • Fremont, CA 94555
  • United States
+1 (510)
Primary Industry
Therapeutic Devices
Other Industries
Medical Supplies
Acquirer
Amgen
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6701 Kaiser Drive
  • Fremont, CA 94555
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abgenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Apr-2006 $2.85B Completed Generating Revenue
4. PIPE 12-Mar-2002 Completed Generating Revenue
3. Grant 02-Jan-2001 Completed
2. IPO 02-Jul-1998 $20M $40M Completed Generating Revenue
1. Early Stage VC 23-Dec-1997 $20M $20M Completed Product Development
To view Abgenix’s complete valuation and funding history, request access »

Abgenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abgenix Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Forward Ventures Venture Capital Minority
LRG Capital PE/Buyout Minority
Lombard Odier Asset Manager Minority
Mehta Partners Hedge Fund Minority
Merlin BioMed Group Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Abgenix Acquisitions (1)

Abgenix’s most recent deal was a Merger/Acquisition with ImmGenics Pharmaceuticals for . The deal was made on 06-Nov-2000.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ImmGenics Pharmaceuticals 06-Nov-2000 Merger/Acquisition Biotechnology
To view Abgenix’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Abgenix FAQs

  • When was Abgenix founded?

    Abgenix was founded in 1996.

  • Where is Abgenix headquartered?

    Abgenix is headquartered in Fremont, CA.

  • What is the size of Abgenix?

    Abgenix has 440 total employees.

  • What industry is Abgenix in?

    Abgenix’s primary industry is Therapeutic Devices.

  • Is Abgenix a private or public company?

    Abgenix is a Private company.

  • What is the current valuation of Abgenix?

    The current valuation of Abgenix is .

  • What is Abgenix’s current revenue?

    The current revenue for Abgenix is .

  • How much funding has Abgenix raised over time?

    Abgenix has raised $70M.

  • Who are Abgenix’s investors?

    Forward Ventures, LRG Capital, Lombard Odier, Mehta Partners, and Merlin BioMed Group are 5 of 7 investors who have invested in Abgenix.

  • When was Abgenix acquired?

    Abgenix was acquired on 01-Apr-2006.

  • Who acquired Abgenix?

    Abgenix was acquired by Amgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »